<p>Progression of participants in the trial, including those who met the exclusion criteria, those who withdrew, and those who were lost to follow up.</p
There is a lack of guidance for developing progression criteria (PC) within feasibility studies. We ...
<p>Flow diagram of exclusions and follow-up of participants from the SABRE study, UK.</p
Progression to negativity by treatment group (drug1 and watch-wait) among patients who were positive...
<p>“Withdrawn” indicates participants’ withdrawal from trial and all associated research activities....
<p>* The patient who was lost to follow-up at 3 months was excluded from the analysis of the 3 month...
<p>A flow chart explaining the various steps from screening, to inclusion and exclusion, and final a...
The steps taken to identify trials that were unambiguously Indian or multinational trials, and those...
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
Recruitment, enrollment, randomization, withdrawal and completion of subjects.</p
<p>Baseline characteristics of the remaining participants, and those lost to follow-up.</p
<p>Completer: Participant who attended all six intervention sessions; Partial Completer: Participant...
Demographic and clinical characteristics of enrolled participants compared to those who were exclude...
Inclusion and exclusion criteria to be followed during the recruitment of participants for the field...
<p>The participants, the exclusion criteria and the data sources for the current study.</p
<p>The number of individuals screened, randomized, allocated and withdrawn from the trial.</p
There is a lack of guidance for developing progression criteria (PC) within feasibility studies. We ...
<p>Flow diagram of exclusions and follow-up of participants from the SABRE study, UK.</p
Progression to negativity by treatment group (drug1 and watch-wait) among patients who were positive...
<p>“Withdrawn” indicates participants’ withdrawal from trial and all associated research activities....
<p>* The patient who was lost to follow-up at 3 months was excluded from the analysis of the 3 month...
<p>A flow chart explaining the various steps from screening, to inclusion and exclusion, and final a...
The steps taken to identify trials that were unambiguously Indian or multinational trials, and those...
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
Recruitment, enrollment, randomization, withdrawal and completion of subjects.</p
<p>Baseline characteristics of the remaining participants, and those lost to follow-up.</p
<p>Completer: Participant who attended all six intervention sessions; Partial Completer: Participant...
Demographic and clinical characteristics of enrolled participants compared to those who were exclude...
Inclusion and exclusion criteria to be followed during the recruitment of participants for the field...
<p>The participants, the exclusion criteria and the data sources for the current study.</p
<p>The number of individuals screened, randomized, allocated and withdrawn from the trial.</p
There is a lack of guidance for developing progression criteria (PC) within feasibility studies. We ...
<p>Flow diagram of exclusions and follow-up of participants from the SABRE study, UK.</p
Progression to negativity by treatment group (drug1 and watch-wait) among patients who were positive...